Parallax Volatility Advisers, L.P. Bio N Tech Se Put Options Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

Put Options

14 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $1.98 Million - $2.53 Million	-24,600 Reduced 41.28%	35,000 $2.81 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $4.45 Million - $5.62 Million	-50,000 Reduced 45.62%	59,600 $5.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.91 - $112.75 $2.31 Million - $2.86 Million	-25,400 Reduced 18.81%	109,600 $11.6 Million
Q3 2023 Nov 14, 2023	SELL	$98.5 - $125.08 $4.43 Million - $5.63 Million	-45,000 Reduced 25.0%	135,000 $14.7 Million
Q2 2023 Aug 14, 2023	BUY	$102.58 - $129.66 $17.6 Million - $22.2 Million	171,500 Added 2017.65%	180,000 $19.4 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $5.76 Million - $7.22 Million	-47,000 Reduced 84.68%	8,500 $1.06 Million
Q4 2022 Feb 14, 2023	SELL	$118.43 - $186.05 $165,802 - $260,470	-1,400 Reduced 2.46%	55,500 $8.34 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $178,710 - $256,354	1,400 Added 2.52%	56,900 $7.67 Million
Q2 2022 Aug 15, 2022	SELL	$123.25 - $186.24 $20.3 Million - $30.7 Million	-164,900 Reduced 74.82%	55,500 $8.28 Million
Q1 2022 May 16, 2022	SELL	$126.25 - $231.85 $8.09 Million - $14.9 Million	-64,100 Reduced 22.53%	220,400 $37.6 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $4.31 Million - $7.21 Million	-19,900 Reduced 6.54%	284,500 $73.3 Million
Q3 2021 Nov 15, 2021	BUY	$205.93 - $447.23 $23.6 Million - $51.2 Million	114,400 Added 60.21%	304,400 $83.1 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $13 Million - $27.8 Million	115,000 Added 153.33%	190,000 $42.5 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $6.43 Million - $8.96 Million	75,000 New	75,000 $8.19 Million

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account